| Assessment of vasoconstrictive potential of D-lysergic acid using an isolated bovine lateral saphenous vein bioassay. | |
| | |
MedLine Citation:
|
PMID: 17032812 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Vasoconstriction has been associated with several symptoms of fescue toxicosis thought to be alkaloid induced. Lysergic acid, an ergot alkaloid, has been proposed as a toxic component of endophyte-infected tall fescue. The objective of this study was to examine the vasoconstrictive potential of D-lysergic acid using a bovine lateral (cranial branch) saphenous vein bioassay. Before testing lysergic acid, validation of the bovine lateral saphenous vein bioassay for use with a multimyograph apparatus was conducted using a dose-response to norepinephrine to evaluate the effects of limb of origin (right vs. left) and overnight storage on vessel contractile response. Segments (2 to 3 cm) of the cranial branch of the lateral saphenous vein were collected from healthy mixed breed cattle (n = 12 and n = 7 for the lysergic acid and norepinephrine experiments, respectively) at local abattoirs. Tissue was placed in modified Krebs-Henseleit, oxygenated buffer and kept on ice or stored at 2 to 8 degrees C until used. Veins were trimmed of excess fat and connective tissue, sliced into 2- to 3-mm sections, and suspended in a myograph chamber containing 5 mL of oxygenated Krebs-Henseleit buffer (95% O2, 5% CO2; pH = 7.4; 37 degrees C). Tissue was allowed to equilibrate at 1 g of tension for 90 min before initiation of treatment additions. Increasing doses of norepinephrine (1 x 10(-8) to 5 x 10(-4) M) or lysergic acid (1 x 10(-11) to 1 x 10(-4) M) were administered every 15 min after buffer replacement. Data were normalized as a percentage of the contractile response induced by a reference dose of norepinephrine. Veins from both left and right limbs demonstrated contractions in a dose-dependent manner (P < 0.01) but did not differ between limbs. There were no differences in dose-response to norepinephrine between tissue tested the day of dissection and tissue tested 24 h later. Exposure of vein segments to increasing concentrations of lysergic acid did not result in an appreciable contractile response until the addition of 1 x 10(-4) M lysergic acid (15.6 +/- 2.3% of the 1 x 10(-4) M norepinephrine response). These data indicate that only highly elevated concentrations of lysergic acid result in vasoconstriction. Thus, in relation to the symptoms associated with vasoconstriction, lysergic acid may only play a minor role in the manifestation of fescue toxicosis. |
| | |
Authors:
|
J L Klotz; L P Bush; D L Smith; W D Shafer; L L Smith; A C Vevoda; A M Craig; B C Arrington; J R Strickland |
Publication Detail:
|
Type: In Vitro; Journal Article |
Journal Detail:
|
Title: Journal of animal science Volume: 84 ISSN: 1525-3163 ISO Abbreviation: J. Anim. Sci. Publication Date: 2006 Nov |
Date Detail:
|
Created Date: 2006-10-11 Completed Date: 2006-12-18 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8003002 Medline TA: J Anim Sci Country: United States |
Other Details:
|
Languages: eng Pagination: 3167-75 Citation Subset: IM |
Affiliation:
|
Forage-Animal Production Research Unit, USDA-ARS, Lexington, KY 40546, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Biological Assay / methods, veterinary Cattle Dose-Response Relationship, Drug Female Lysergic Acid / chemistry, pharmacology* Male Molecular Structure Norepinephrine / administration & dosage, pharmacology Reproducibility of Results Saphenous Vein / drug effects* Vasoconstriction / drug effects* Vasoconstrictor Agents / pharmacology* |
| Chemical | |
Reg. No./Substance:
|
0/Vasoconstrictor Agents; 51-41-2/Norepinephrine; 82-58-6/Lysergic Acid |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Interindividual variability in plasma concentrations after systemic exposure of swine to dietary dox...
Next Document: Fundamental questions about genes, inactivity, and chronic diseases.